PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
The public activities coordination tool (PACT) provides an overview of the substance-specific activities that authorities are working on under REACH and the CLP Regulation. These activities are being carried out in line with ECHA’s Integrated Regulatory Strategy.
PACT provides up-to-date information on the activities planned, ongoing or completed by ECHA and/or MSCAs for a given substance in the following areas:
- Data generation and assessment – dossier evaluation, substance evaluation, informal hazard assessment (PBT/vPvB/ED).
- Assessment of regulatory needs (ARN).
- Regulatory risk management – harmonised classification and labelling (CLH) , SVHC identification, recommendations for inclusion in the Authorisation List, restriction.
A summary of all the substance-specific activities can be found under ‘Details’ for each entry.
Further information
- Understanding PACT
- Integrated Regulatory Strategy
- Substances of potential concern
- Dossier Evaluation status
- Substance evaluation
- Endocrine disruptor assessment
- PBT assessment
- Assessment of regulatory needs list
- Registry of CLH intentions until outcome
- Registry of SVHC intentions until outcome
- Recommendations for inclusion in the Authorisation list
- Registry of restriction intentions until outcome
Filter the list
The List does not contain any Substances.
| Data generation and assessment | ARN | Regulatory risk management | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pentan-3-one | 202-490-3 | 96-22-0 | - | - | 2 | - | 1 | - | - | - | - | Details |
| 1,3-dihydroxyacetone | 202-494-5 | 96-26-4 | - | - | 1 | - | - | - | - | - | - | Details |
| Butanone oxime | 202-496-6 | 96-29-7 | 1 | - | - | - | - | 1 | - | - | - | Details |
| methyl acrylate; methyl propenoate | 202-500-6 | 96-33-3 | - | - | 4 | - | 1 | 1 | - | - | - | Details |
| Methyl chloroacetate | 202-501-1 | 96-34-4 | - | - | - | - | 1 | - | - | - | - | Details |
| Methylcyclopentane | 202-503-2 | 96-37-7 | - | - | 1 | - | 1 | - | - | - | - | Details |
| Cyclopentanol | 202-504-8 | 96-41-3 | - | - | - | - | 1 | - | - | - | - | Details |
| Imidazolidine-2-thione | 202-506-9 | 96-45-7 | - | - | 1 | - | 1 | - | 1 | - | - | Details |
| Tetrahydro-2-methylfuran | 202-507-4 | 96-47-9 | - | - | 2 | - | 1 | - | - | - | - | Details |
| γ-butyrolactone | 202-509-5 | 96-48-0 | - | - | 1 | - | - | 1 | - | - | - | Details |
| Ethylene carbonate | 202-510-0 | 96-49-1 | 1 | - | 4 | - | 1 | - | - | - | - | Details |
| 6,6'-di-tert-butyl-4,4'-thiodi-m-cresol | 202-525-2 | 96-69-5 | 1 | 1 | 1 | 1 | - | - | - | - | - | Details |
| 2,4-di-tert-butylphenol | 202-532-0 | 96-76-4 | 1 | 1 | 5 | 1 | 1 | - | - | - | - | Details |
| 3-nitro-p-toluic acid | 202-549-3 | 96-98-0 | - | - | - | - | 1 | - | - | - | - | Details |
| 5-sulphosalicylic acid | 202-555-6 | 97-05-2 | - | - | 1 | - | - | - | - | - | - | Details |
| Methyl α-D-glucoside | 202-571-3 | 97-30-3 | - | - | - | - | 1 | - | - | - | - | Details |
| Eugenol | 202-589-1 | 97-53-0 | - | - | - | - | - | 2 | - | - | - | Details |
| 4-o-tolylazo-o-toluidine | 202-591-2 | 97-56-3 | - | - | - | - | - | - | 1 | - | - | Details |
| 2-methylvaleric acid | 202-594-9 | 97-61-0 | - | - | - | - | 1 | - | - | - | - | Details |
| Ethyl isobutyrate | 202-595-4 | 97-62-1 | - | - | - | - | 1 | - | - | - | - | Details |
| Ethyl methacrylate | 202-597-5 | 97-63-2 | 1 | - | 2 | - | 1 | - | - | - | - | Details |
| Itaconic acid | 202-599-6 | 97-65-4 | - | - | 2 | - | - | - | - | - | - | Details |
| Tetramethylthiuram monosulphide | 202-605-7 | 97-74-5 | - | - | 2 | - | - | - | - | - | - | Details |
| Disulfiram | 202-607-8 | 97-77-8 | - | - | 2 | - | - | - | - | - | - | Details |
| N-lauroylsarcosine | 202-608-3 | 97-78-9 | - | - | - | - | 1 | - | - | - | - | Details |